Encompass Health price target raised to $83 from $77 at BofA

BofA raised the firm’s price target on Encompass Health to $83 from $77 and keeps a Buy rating on the shares. Q4 results came in much better than expected “in typical EHC fashion,” but the company guided to 2024 roughly in line with consensus, which “looks like the typical EHC conservatism,” the analyst tells investors in a post-earnings note.